Potassium hydroxide

Suppliers

Names

[ CAS No. ]:
1310-58-3

[ Name ]:
Potassium hydroxide

[Synonym ]:
kizutasaponin K10
Potassium h
Potassium hydroxide
EINECS 215-181-3
lpotassum hydroxide
potassium hydroxyde
potassium hyroxide
potassium hydroxid
Caustic potash
MFCD00003553
Cauloside D

Chemical & Physical Properties

[ Density]:
1.450 g/mL at 20 °C

[ Boiling Point ]:
1320°C

[ Melting Point ]:
361 °C(lit.)

[ Molecular Formula ]:
HKO

[ Molecular Weight ]:
56.106

[ Flash Point ]:
52 °F

[ Exact Mass ]:
55.966446

[ PSA ]:
23.06000

[ Vapour Pressure ]:
1 mm Hg ( 719 °C)

[ Index of Refraction ]:
n20/D 1.421

[ Water Solubility ]:
soluble

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TT2100000
CHEMICAL NAME :
Potassium hydroxide
CAS REGISTRY NUMBER :
1310-58-3
LAST UPDATED :
199712
DATA ITEMS CITED :
29
MOLECULAR FORMULA :
H-K-O
MOLECULAR WEIGHT :
56.11
WISWESSER LINE NOTATION :
KA Q

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
Standard Draize test
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Human
TYPE OF TEST :
Standard Draize test
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rabbit
TYPE OF TEST :
Rinsed with water
ROUTE OF EXPOSURE :
Administration into the eye
SPECIES OBSERVED :
Rodent - rabbit
TYPE OF TEST :
Standard Draize test
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - guinea pig
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
273 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value

MUTATION DATA

TYPE OF TEST :
Cytogenetic analysis
TEST SYSTEM :
Rodent - hamster Ovary
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 225,55,1989 *** REVIEWS *** ACGIH TLV-CL 2 mg/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 TOXICOLOGY REVIEW ARTODN Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- Volume(issue)/page/year: 39,299,1978 *** U.S. STANDARDS AND REGULATIONS *** EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION FEREAC Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- Volume(issue)/page/year: 54,7740,1989 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-AUSTRALIA:TWA 2 mg/m3 JAN 1993 OEL-BELGIUM:STEL 2 mg/m3 JAN 1993 OEL-DENMARK:TWA 2 mg/m3 JAN 1993 OEL-FINLAND:TWA 2 mg/m3 JAN 1993 OEL-FRANCE:STEL 2 mg/m3 JAN 1993 OEL-JAPAN:STEL 2 mg/m3 JAN 1993 OEL-THE NETHERLANDS:TWA 2 mg/m3 JAN 1993 OEL-SWITZERLAND:TWA 2 mg/m3 JAN 1993 OEL-UNITED KINGDOM:TWA 2 mg/m3;STEL 2 mg/m3 JAN 1993 OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH RECOMMENDED EXPOSURE LEVEL (REL) : NIOSH REL TO POTASSIUM HYDROXIDE-air:CL 2 mg/m3 REFERENCE : NIOSH* National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. Volume(issue)/page/year: DHHS #92-100,1992 NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 60440 No. of Facilities: 80620 (estimated) No. of Industries: 340 No. of Occupations: 181 No. of Employees: 1081553 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X3783 No. of Facilities: 543 (estimated) No. of Industries: 11 No. of Occupations: 16 No. of Employees: 6722 (estimated) No. of Female Employees: 2651 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 60440 No. of Facilities: 74278 (estimated) No. of Industries: 346 No. of Occupations: 221 No. of Employees: 1959889 (estimated) No. of Female Employees: 797390 (estimated)

Safety Information

[ Symbol ]:

GHS05, GHS07

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H290-H302-H314

[ Precautionary Statements ]:
P280-P301 + P312 + P330-P303 + P361 + P353-P304 + P340 + P310-P305 + P351 + P338

[ Personal Protective Equipment ]:
Faceshields;full-face respirator (US);Gloves;Goggles;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter

[ Hazard Codes ]:
C: Corrosive;F: Flammable;T: Toxic;Xi: Irritant;

[ Risk Phrases ]:
R22;R35

[ Safety Phrases ]:
S7-S16-S36/37-S45-S36/37/39-S26

[ RIDADR ]:
UN 2924 3/PG 2

[ WGK Germany ]:
1

[ RTECS ]:
TT2100000

[ Packaging Group ]:
II

[ Hazard Class ]:
8

[ HS Code ]:
2815200000

Precursor & DownStream

Precursor

DownStream

  • 3-Hydroxy-2-naphthoic acid
  • 2,4-Pentanedione,ion(1-), potassium salt (1:1)
  • Hydroxylamine
  • 1,1-Ethenedithiol,2-nitro-, potassium salt (1:2)
  • 7-Chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
  • haloxyfop-P
  • Potassium formate
  • Neopentyl glycol
  • Rancho
  • 2,4-Diphenylimidazole

Customs

[ HS Code ]: 2815200000

Articles

Synergistic activity of tenofovir and nevirapine combinations released from polycaprolactone matrices for potential enhanced prevention of HIV infection through the vaginal route.

Eur. J. Pharm. Biopharm. 88(2) , 406-14, (2014)

Polycaprolactone (PCL) matrices were simultaneously loaded with the antiviral agents, tenofovir (TFV) and nevirapine (NVP), in combination to provide synergistic activity in the prevention of HIV tran...

Engineering the oxygen sensing regulation results in an enhanced recombinant human hemoglobin production by Saccharomyces cerevisiae.

Biotechnol. Bioeng. 112(1) , 181-8, (2014)

Efficient production of appropriate oxygen carriers for transfusions (blood substitutes or artificial blood) has been pursued for many decades, and to date several strategies have been used, from synt...

Detailed characterization of a long-term rodent model of critical illness and recovery.

Crit. Care Med. 43(3) , e84-96, (2015)

To characterize a long-term model of recovery from critical illness, with particular emphasis on cardiorespiratory, metabolic, and muscle function.Randomized controlled animal study.University researc...


More Articles


Related Compounds

  • Potassium hydroxide
  • Potassium hydroxide
  • Potassium hydroxide
  • potassium hydroxide-O-d
  • potassium hydroxide hydrate
  • CESIUM HYDROXIDE mixed with POTASSIUM HYDROXIDE
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • (4-(5-chloro-2-methylphenyl)piperazin-1-yl)(1,3-dimethyl-1H-pyrazol-4-yl)methanone hydrochloride
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine
  • 4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide